» Articles » PMID: 27647871

Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus Pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation

Overview
Journal Infect Immun
Date 2016 Sep 21
PMID 27647871
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza A virus (IAV) and Streptococcus pneumoniae are major causes of respiratory tract infections, particularly during coinfection. The synergism between these two pathogens is characterized by a complex network of dysregulated immune responses, some of which last until recovery following IAV infection. Despite the high serotype diversity of S. pneumoniae and the serotype replacement observed since the introduction of conjugate vaccines, little is known about pneumococcal strain dependency in the enhanced susceptibility to severe secondary S. pneumoniae infection following IAV infection. Thus, we studied how preinfection with IAV alters host susceptibility to different S. pneumoniae strains with various degrees of invasiveness using a highly invasive serotype 4 strain, an invasive serotype 7F strain, and a carrier serotype 19F strain. A murine model of pneumococcal coinfection during the acute phase of IAV infection showed a significantly increased degree of pneumonia and mortality for all tested pneumococcal strains at otherwise sublethal doses. The incidence and kinetics of systemic dissemination, however, remained bacterial strain dependent. Furthermore, we observed strain-specific alterations in the pulmonary levels of alveolar macrophages, neutrophils, and inflammatory mediators ultimately affecting immunopathology. During the recovery phase following IAV infection, bacterial growth in the lungs and systemic dissemination were enhanced in a strain-dependent manner. Altogether, this study shows that acute IAV infection predisposes the host to lethal S. pneumoniae infection irrespective of the pneumococcal serotype, while the long-lasting synergism between IAV and S. pneumoniae is bacterial strain dependent. These results hold implications for developing tailored therapeutic treatment regimens for dual infections during future IAV outbreaks.

Citing Articles

Natural Carriage of Streptococcus pneumoniae Is Associated With Increased Experimental Pneumococcal Carriage but Reduced Conjugate Vaccine Efficacy in a Human Challenge Model.

Galafa B, Chikaonda T, Kudowa E, Sichone S, Sibale L, Thole F J Infect Dis. 2024; 231(2):334-343.

PMID: 38984706 PMC: 11841637. DOI: 10.1093/infdis/jiae341.


The host transcriptional response to superinfection by influenza A virus and .

Cohn O, Yankovitz G, Mandelboim M, Peshes-Yaloz N, Brandes R, Bacharach E mSystems. 2024; 9(4):e0104823.

PMID: 38446104 PMC: 11019783. DOI: 10.1128/msystems.01048-23.


Infection with different human influenza A subtypes affects the period of susceptibility to secondary bacterial infections in ferrets.

Mifsud E, Farrukee R, Hurt A, Reading P, Barr I FEMS Microbes. 2023; 3:xtac011.

PMID: 37332495 PMC: 10117794. DOI: 10.1093/femsmc/xtac011.


CRISPR arrays as high-resolution markers to track microbial transmission during influenza infection.

Zhang L, Rahman J, Chung M, Lashua L, Gordon A, Balmaseda A Microbiome. 2023; 11(1):136.

PMID: 37330554 PMC: 10276449. DOI: 10.1186/s40168-023-01568-0.


Memory Th17 cell-mediated protection against lethal secondary pneumococcal pneumonia following influenza infection.

Li Y, Yang Y, Chen D, Wang Y, Zhang X, Li W mBio. 2023; 14(4):e0051923.

PMID: 37222516 PMC: 10470593. DOI: 10.1128/mbio.00519-23.


References
1.
Weinberger D, Trzcinski K, Lu Y, Bogaert D, Brandes A, Galagan J . Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog. 2009; 5(6):e1000476. PMC: 2689349. DOI: 10.1371/journal.ppat.1000476. View

2.
Blomberg C, Dagerhamn J, Dahlberg S, Browall S, Fernebro J, Albiger B . Pattern of accessory regions and invasive disease potential in Streptococcus pneumoniae. J Infect Dis. 2009; 199(7):1032-42. DOI: 10.1086/597205. View

3.
de Vos A, Dessing M, Lammers A, De Porto A, Florquin S, de Boer O . The polysaccharide capsule of Streptococcus pneumonia partially impedes MyD88-mediated immunity during pneumonia in mice. PLoS One. 2015; 10(2):e0118181. PMC: 4336322. DOI: 10.1371/journal.pone.0118181. View

4.
McCullers J . The co-pathogenesis of influenza viruses with bacteria in the lung. Nat Rev Microbiol. 2014; 12(4):252-62. DOI: 10.1038/nrmicro3231. View

5.
Wartha F, Beiter K, Albiger B, Fernebro J, Zychlinsky A, Normark S . Capsule and D-alanylated lipoteichoic acids protect Streptococcus pneumoniae against neutrophil extracellular traps. Cell Microbiol. 2007; 9(5):1162-71. DOI: 10.1111/j.1462-5822.2006.00857.x. View